20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T0267 | Zonisamide | AD 810,CI 912 | Calcium Channel , Sodium Channel , Carbonic Anhydrase |
Zonisamide (AD 810), a sulfonamide anticonvulsant, is approved for use as an adjunctive treatment in adults with partial-onset seizures. It may inhibit a carbonic anhydrase although this is not one of the main mechanisms... | |||
T0086 | Galanthamine hydrobromide | Galantamine hydrobromide,Galanthamine HBr | AChR , AChE |
Galanthamine hydrobromide (Galantamine hydrobromide), a long-acting and centrally active AChE inhibitor (IC50:410 nM), is an allosteric potentiator at neuronal nicotinic ACh receptors. | |||
T28750 | Sembragiline | RG-1577,EVT-302,RO-4602522,RO4602522,RG1577,EVT302 | MAO |
Sembragiline (EVT-302) is a selective MAO-B inhibitor for the study of Alzheimer's disease (AD). | |||
T28441 | PPI-1019 | PPI1019,Apan | Beta Amyloid |
PPI-1019 is an APP (β-amyloid A4) inhibitor for the treatment of neurological disorders and the study of Alzheimer's disease (AD). | |||
T21956 | GSK3β inhibitor II | GSK-3 | |
GSK3β inhibitor II is a GSK3β inhibitor. GSK3β inhibitor II exhibits the research potential of Alzheimer's disease (AD). | |||
TP1140L | Neuropeptide Y (29-64), amide, human acetate | Neuropeptide Y Receptor | |
Neuropeptide Y (29-64), amide, human acetate is involved in Alzheimer's disease (AD) and protects rat cortical neurons against β-Amyloid toxicity. | |||
T8583 | Tenilsetam | 3-(2-thienyl)- (9CI),Piperazinone | Others |
Tenilsetam (Piperazinone) is an endonuclease modulator; a nootropic agent and advanced glycation end product (AGE) inhibitor having potential for Alzheimer's disease (AD) treatment. | |||
T8448 | ZSET1446 | ZSET-1446,ST-101 | Calcium Channel , AChR |
ZSET1446 (ST-101) is a T-type calcium channel activator potentially for the treatment of learning deficits in various types of Alzheimer disease (AD) models. | |||
T4955 | Saponaretin | Isovitexin,Apigenin-6-C-glucoside | Apoptosis , Antioxidant |
saponaretin, an active component of many traditional Chinese medicines, shows various activities, such as anti-oxidant, anti-inflammatory, anti-alzheimer disease (AD) effects and so on. | |||
TN1341 | 8-Deoxygartanin | Beta Amyloid , NF-κB , Parasite | |
8-Deoxygartanin is a butyrylcholinesterase (BChE) selective inhibitor, it exhibits significant inhibition of self-induced α2-amyloid (Aα2) aggregation, it has multifunctional activities against Alzheimer's disease (AD) a... | |||
TP2194L | Neuropeptide Y (scrambled) Acetate | Pro-Neuropeptide Y (scrambled) Acetate,NPY (scrambled) Acetate | Others |
Neuropeptide Y (scrambled) Acetate (Pro-Neuropeptide Y (scrambled) Acetate) is a scrambled peptide of Neuropeptide Y that has been implicated in Alzheimer's disease (AD) and may have neuroprotective effects. | |||
T9379 | L-Threonic acid magnesium salt | Others | |
L-Threonic acid magnesium salt (L-TAMS) increases synapse density and memory ability in both aged rats and late stage Alzheimer’s disease (AD) model mice. | |||
T77054 | Lecanemab | BAN-2401 | Beta Amyloid |
Lecanemab (BAN-2401) is an IgG1 monoclonal antibody targeting soluble aggregated β-amyloid (Abeta) with activity against oligomers, protofibrils, and insoluble protofibrils, and may be useful in the study of Alzheimer's ... | |||
T2507 | Azeliragon | TTP488 | Beta Amyloid , advanced glycation end products |
Azeliragon (TTP488) is an antagonist at the Receptor for Advanced Glycation End products; is evaluated as a potential treatment for patients with mild-to-moderate Alzheimer_acute_s disease (AD). | |||
T63540 | Astrophloxine | Beta Amyloid | |
Astrophloxine is a fluorescent imaging probe that targets antiparallel dimers.Astrophloxine can be used to detect aggregated Aβ in brain tissue and cerebrospinal fluid samples from Alzheimer's disease (AD) mice. | |||
TN1472 | Cassiaside | Beta-Secretase , BACE | |
Cassiaside is a naphthyl ketone glycoside that inhibits BACE1 (IC50= 4.45 μM; Ki=9.85 μM).Cassiaside exhibits significant hepatoprotective effects against galactosamine injury and has potential anti-Alzheimer's disease (... | |||
T60150 | (1S,2R)-Alicapistat | Cysteine Protease | |
(1S,2R)-Alicapistat ((1S,2R)-ABT-957) is a highly efficient, orally active compound that selectively inhibits human calpains 1 and 2, with promising implications for Alzheimer's disease (AD) therapy [1]. This compound ef... | |||
T9062 | CA77.1 | Autophagy | |
CA77.1(CA) is a novel chaperon-mediated autophagy (CMA) activator for the treatment of Alzheimer's disease (AD). | |||
T60739L | Y13g dihydrochloride | Y13g 2HCl(T60739 Free base) | IL Receptor , AChE |
Y13g dihydrochloride is a potent inhibitor of interleukin 6 (IL-6) and acetylcholinesterase (AChE) (both targets of Alzheimer's disease (AD) progression are related). Y13g dihydrochloride reverses STZ-induced memory defi... | |||
T77042 | Aducanumab | BIIB037 | Beta Amyloid |
Aducanumab (BIIB037), A selective human immunoglobulin gamma-1 (IgG1) monoclonal antibody, targets the clustered form of amyloid beta (Aβ). Aducanumab shows brain permeability and may be used to treat Alzheimer's disease... |